Wachovia upgraded the Generic Drug Sector from Market Weight to Overweight and upgraded Teva Phama (Nasdaq: TEVA) and Watson Phama ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE